Centaurus Financial’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-67,723
Closed -$496K 858
2024
Q2
$496K Sell
67,723
-13,239
-16% -$116K 0.03% 392
2024
Q1
$810K Buy
+80,962
New +$709K 0.06% 282
2022
Q1
Sell
-4,360
Closed -$112K 952
2021
Q4
$112K Buy
+4,360
New +$120K 0.01% 864
2021
Q3
Sell
-2,555
Closed -$102K 931
2021
Q2
$102K Sell
2,555
-5,445
-68% -$221K 0.01% 867
2021
Q1
$339K Buy
8,000
+2,356
+42% +$109K 0.03% 470
2020
Q4
$206K Buy
+5,644
New +$168K 0.02% 550

Other funds holding MSOS

Centaurus Financial's MSOS Position: Q3 2024 in Review

Centaurus Financial sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q3 2024, closing a stake of 67,723 shares — an estimated $496K sold.

Centaurus Financial first reported a position in MSOS in Q4 2020 and held it in 6 quarters. The position peaked at $810K in Q1 2024. 171 funds tracked by Wall St. Rank hold MSOS as of Q3 2024.

  • Centaurus Financial reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q3 2024 after selling out during the quarter.
  • Centaurus Financial sold 67,723 AdvisorShares Pure US Cannabis ETF shares in Q3 2024, an estimated $496K.
  • Centaurus Financial first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2020 and held it in 6 quarters.
  • Centaurus Financial's AdvisorShares Pure US Cannabis ETF position peaked at $810K in Q1 2024.
  • 171 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q3 2024.

Based on Centaurus Financial's 13F filing for Q3 2024, filed 12 Nov 2024.